Dome

Dome Therapeutics is a private biotechnology company focused on applying stem cell-based technologies to central nervous system disorders, including cancer and neurodegenerative diseases. Publicly available descriptions indicate the company programs patient-derived autologous stem cells ex vivo using biomaterials and nanomedicine approaches. The company appears to be an early-stage platform biotech rather than a clinically advanced drug developer, and no clearly disclosed human clinical-stage asset list was identified from accessible sources. Available third-party profiles place the company in the biotechnology and oncology/life sciences categories and indicate it remains active as a private venture-backed business.